Literature DB >> 11434193

Statins enhance arachidonic acid synthesis in hypercholesterolemic patients.

P Risé1, F Pazzucconi, C R Sirtori, C Galli.   

Abstract

BACKGROUND AND AIM: It has been shown that statins enhance arachidonic acid biosynthesis from linoleic acid in vitro, and there is also evidence that statin-treated patients have high plasma and cellular arachidonic acid levels. The aim of this study was to investigate the possible effects of statins on the desaturating steps of arachidonic acid biosynthesis in patients. METHODS AND
RESULTS: Plasma polyunsaturated fatty acids (percentages and concentrations), total cholesterol, LDL-cholesterol and triglycerides were measured in three groups of hypercholesterolemic patients before and after treatment with statins or fibrates for about three years, or before and after four months on a low-fat diet. As expected, there was a significant reduction in plasma total cholesterol (-23%) and LDL-cholesterol (-27%) levels in the statin group, and a significant reduction in triglycerides (-29%) and some decrease in total cholesterol (-12%) in the fibrate group; no change was observed in the control group. The selective increase in plasma arachidonic acid levels (in terms of absolute concentration and as a percentage of total fatty acids) was of the same order as the reduction in cholesterol, and the selective increase in the product/precursor ratios for delta 5 desaturation in the statin group indicated that this key step in arachidonic acid synthesis is affected.
CONCLUSIONS: Our data show that an increase in arachidonic acid synthesis due to enhanced delta 5 desaturation is a major effect of statin treatment, and has the same order of magnitude as the reduction in plasma cholesterol levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434193

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  10 in total

Review 1.  Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials.

Authors:  Amirhossein Sahebkar; Luis E Simental-Mendía; Claudio Pedone; Gianna Ferretti; Petr Nachtigal; Simona Bo; Giuseppe Derosa; Pamela Maffioli; Gerald F Watts
Journal:  Br J Clin Pharmacol       Date:  2016-02-02       Impact factor: 4.335

Review 2.  How lipids may affect risk for suicidal behavior.

Authors:  Federico M Daray; J John Mann; M Elizabeth Sublette
Journal:  J Psychiatr Res       Date:  2018-06-12       Impact factor: 4.791

3.  Effects of simvastatin on blood pressure in hypercholesterolemic patients: An open-label study in patients with hypertension or normotension.

Authors:  Adriana Branchi; Anna Maria Fiorenza; Adriana Torri; Cristina Berra; Emanuela Colombo; Angelo Rovellini; Domenico Sommariva
Journal:  Curr Ther Res Clin Exp       Date:  2004-05

Review 4.  Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

Authors:  Marco Tuccori; Sabrina Montagnani; Stefania Mantarro; Alice Capogrosso-Sansone; Elisa Ruggiero; Alessandra Saporiti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

5.  Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study.

Authors:  Rima Kaddurah-Daouk; Rebecca A Baillie; Hongjie Zhu; Zhao-Bang Zeng; Michelle M Wiest; Uyen Thao Nguyen; Steven M Watkins; Ronald M Krauss
Journal:  Metabolomics       Date:  2010-04-01       Impact factor: 4.290

6.  Pharmacological modulation of fatty acid desaturation and of cholesterol biosynthesis in THP-1 cells.

Authors:  P Risé; S Ghezzi; M G Levati; R Mirtini; C Colombo; C Galli
Journal:  Lipids       Date:  2003-08       Impact factor: 1.880

Review 7.  The Role of n-3 Long Chain Polyunsaturated Fatty Acids in Cardiovascular Disease Prevention, and Interactions with Statins.

Authors:  Julia K Bird; Philip C Calder; Manfred Eggersdorfer
Journal:  Nutrients       Date:  2018-06-15       Impact factor: 5.717

8.  Arachidonic acid and colorectal adenoma risk: a Mendelian randomization study.

Authors:  Chelsea A Isom; Martha J Shrubsole; Qiuyin Cai; Walter E Smalley; Reid M Ness; Wei Zheng; Harvey J Murff
Journal:  Clin Epidemiol       Date:  2018-12-18       Impact factor: 4.790

Review 9.  Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2008-10-15       Impact factor: 3.876

10.  Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism.

Authors:  Elisabeth Altmaier; Gisela Fobo; Margit Heier; Barbara Thorand; Christine Meisinger; Werner Römisch-Margl; Melanie Waldenberger; Christian Gieger; Thomas Illig; Jerzy Adamski; Karsten Suhre; Gabi Kastenmüller
Journal:  Eur J Epidemiol       Date:  2014-05-10       Impact factor: 8.082

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.